The glucose dysmetabolism in the acute phase of non-diabetic ST-elevation myocardial infarction: From insulin resistance to hyperglycemia

Acta Diabetologica

Volumn 50, Issue 3, 2013, Pages 293-300

  Lazzeri, Chiara ^a   Valente, Serafina ^a   Chiostri, Marco ^a   Attanà, Paola ^a   Picariello, Claudio ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Hyperglycemia; Insulin resistance; Non diabetic; PCI; Prognosis; STEMI

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HEART ARRHYTHMIA; HEART MUSCLE REVASCULARIZATION; HOMEOSTATIC MODEL ASSESSMENT INDEX; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INTENSIVE CARE UNIT; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CATECHOLAMINES; COMORBIDITY; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; INTENSIVE CARE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STRESS, PHYSIOLOGICAL;

EID: 84879244619     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-011-0325-6     Document Type: Article

References (40)

1. Opie LH (2008) Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia. Circulation 117(17):2172-2177
2. Oswald GA, Smith CC, Betteridge DJ et al (1986) Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 293(6552):917-922
3. Lazzeri C, Tarquini R, Giunta F, Gensini GF (2009) Glucose dysmetabolism and prognosis in critical illness. Intern Emerg Med 4(2):147-156
4. Deedwania P, Kosiborod M, Barrett E et al. (2008) American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity and Metabolism. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117(12):1610-1619
5. Kosiborod M, Rathore SS, Inzucchi SE (2005) Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111(23):3078-3086
6. Kosiborod M, Inzucchi SE, Krumholz HM et al (2008) Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117(8):1018-1027
7. Kosiborod M, Inzucchi SE, Krumholz HM et al (2009) Glucose normalization and outcomes in patients with acute myocardial infarction. Arch Intern Med 169(5):438-446
8. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M (2005) Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 26(13):1255-1261
9. Goyal A, Mahaffey KW, Garg J et al (2006) Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 27(11):1289-1297
10. Suleiman M, Hammerman H, Boulos M et al (2005) Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 111(6):754-760
11. Lazzeri C, Chiostri M, Sori A, Valente S, Gensini GF (2010) Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement. J Cardiovasc Med 11(1):7-13
12. Nishio K, Shigemitsu M, Kusuyama T, Fukui T, Kawamura K, Itoh S, Konno N, Katagiri T (2006) Insulin resistance in nondiabetic patients with acute myocardial infarction. Cardiovasc Revasc Med 7(2):54-60
13. Wallander M, Bartnik M, Efendic S (2005) Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia 48(11):2229-2235
14. Lazzeri C, Sori A, Chiostri M, Gensini GF, Valente S (2009) Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol 26(10):856-862
15. Saberi F, Heyland D, Lam M, Rapson D, Jeejeebhoy K (2008) Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study. JPEN 32(3):227-235
16. Valente S, Lazzeri C, Chiostri M, Chiostri M, Giglioli C, Sori A, Tigli S, Gensini GF (2009) NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol 132(1):84-89
17. Valente S, Lazzeri C, Saletti E, Chiostri M, Gensini GF (2008) Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence. J Cardiovasc Med 9(11):1083-1087
18. Buiatti E, Barchielli A, Marchionni N et al (2003) Determinants of treatment strategies and survival in acute myocardial infarction: a population-based study in the Florence district, Italy: results of the acute myocardial infarction Florence registry (AMI-Florence). Eur Heart J 24(13):1195-1203
19. European Association for Percutaneous Cardiovascular Interventions, Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization: the task force on myocardial revascularization of the european society of cardiology (ESC) and the european association for cardio-thoracic surgery (EACTS). Eur Heart J 31(20):2501-2555
20. Van de Werf F, Bax J, Betriu A et al (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European society of cardiology. Eur Heart J 29(23):2909-2945
21. Huggett AST, Nixon DA (1957) Use of glucose oxidase peroxidase and Odianisine in the determination of blood and urine glucose. Lancet 273:368-372
22. Hales CN, Randle PJ (1963) Immunoassay of insulin with insulin-antibody precipitate. Biochem J 88:137-144
23. Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604-612
24. Teichholz LE, Kreulen T, Herman MV, Gorlin R (1979) Problems in echocar-diographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 37:7-11
25. Balkau B, Charles M, For the European Group for the Study of Insulin Resistance (EGIR) (1999) Comment on the provisional report from the WHO consultation. Diabet Med 16:442-443
26. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2011) Acute glucose dysmetabolism in the elderly with ST elevation myocardial infarction submitted to mechanical revascularization. Int J Cardiol Feb 21. [Epub ahead of print]
27. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2011) Correlates of acute insulin resistance in the early phase of non-diabetic ST-elevation myocardial infarction. Diabetes Vasc Dis Res 8(1):35-42
28. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) Acute glucose dysmetabolism in the early phase of ST-elevation myocardial infarction: the age response. Diabetes Vasc Dis Res 7(2):131-137
29. Knobl P, Schernthaner G, Schnack C et al (1994) Haemostatic abnormalities persist despite glycemia improvement by insulin therapy in lean type 2 diabetic patients. Thromb Haemost 71:692-697
30. Ceriello A (1993) Coagulation activation in diabetes mellitus: role of hyperglycemia in therapeutic prospects. Diabetologia 36:1119-1125
31. Marfella R, Siniscalchi M, Esposito K et al (2003) Effects of stress hyperglycemia on acute myocardial infarction. Diabetes 26:3129-3135
32. Zauner A, Nimmerrichter P, Anderwald C, Bishof M et al (2007) Severity of insulin resistance in critically ill medical patients. Metab Clin Exp 56:1-5
33. Young LH, Renfu Y, Russel R, Hu X et al (1997) Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation 95:415-422
34. Garcia RG, Rincon MY, Arenas WD et al (2011) Hyperinsulinemia is a predictor of new cardiovascular events in Colombina patients with a first myocardial infarction. Int J Cardiol 148(1):85-90
35. Ceriello A, Zarich SW, Testa R (2009) Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. JACC 53:S9-S13
36. Li L, Messina JL (2009) Acute insulin resistance following injury. Trend Endocrinol Metab 20:429-435
37. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) In-hospital peak glycemia and prognosis in STEMI patients without previously known diabetes. Eur J Cardiovasc Prev Rehabil 17(4):419-423
38. Holzinger U, Kitberger R, Furhmann V, Funk GC, Madl C, Ratheiser K (2007) Correlation of calculated indices of insulin resistance (QUICKI and HOMA) with the euglycaemic hyperinsulinaemic clamp technique for evaluating insulin resistance in critically ill patients. Eur J Anaesthesiol 24:966-970
39. Muniyappa R, Lee S, Chen H, Quon MJ (2008) Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 294(1):E15-E26
40. Basi S, Pupim LB, Simmons EM, Sezer MT, Shyr Y, Freedman S et al (2005) Insulin resistance in critically ill patients with acute renal failure. Am J Physiol Renal Physiol 289:F259-F264